Organic Acids (Urine): What Your Number Changes About Your Treatment

What Urine Organic Acids Actually Measure

A urine organic acids test captures small carbon-chain molecules excreted after metabolic reactions run their course. Think of it as reading the exhaust from your body's cellular machinery. When an enzymatic step slows down because a cofactor is missing or a pathway is congested, the substrate backs up and spills into urine at measurable concentrations.

The Genova NutrEval and standalone Organic Acids Profile organizes results into functional clusters rather than presenting them as a flat list of numbers. Each cluster tells a distinct story.

The Eight Functional Clusters

1. Mitochondrial energy production. Krebs-cycle intermediates like succinic acid, fumaric acid, and malic acid reflect how efficiently mitochondria convert nutrients into ATP. Elevated citric acid cycle intermediates often signal a functional B-vitamin bottleneck or frank mitochondrial dysfunction.

2. B-vitamin cofactor markers. Methylmalonic acid (MMA) measures functional B12 sufficiency independently of serum B12. A urine MMA above 3.56 mmol/mol creatinine in adults suggests intracellular B12 deficiency even when serum B12 reads normal (PMID 28965605). Xanthurenate and kynurenate track functional B6. Formiminoglutamic acid (FIGLU) tracks functional folate.

3. Neurotransmitter metabolites. Homovanillic acid (HVA) and vanillylmandelic acid (VMA) reflect dopamine and norepinephrine turnover. Quinolinic acid, a downstream tryptophan metabolite, can indicate neuroinflammation when elevated above 2.6 mmol/mol creatinine.

4. Oxidative stress. 8-Hydroxy-2-deoxyguanosine (8-OHdG) measures oxidative DNA damage. A 2022 meta-analysis covering 9,110 participants linked elevated 8-OHdG to all-cause cardiovascular risk (RR 1.36, 95% CI 1.18-1.57) (PMID 35659099).

5. Detoxification and amino acid markers. Pyroglutamic acid signals glutathione depletion when high. 2-Hydroxybutyric acid rises in early insulin resistance, preceding fasting glucose changes by years.

6. Gut microbial byproducts. This cluster is often the most clinically actionable. Arabinose is a yeast/fungal fermentation marker. HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) is produced by Clostridia species and has been linked to dopamine dysregulation in small case series (PMID 11370861).

7. Ketone and fatty acid oxidation. Ethylmalonic acid and adipic acid rise when mitochondrial beta-oxidation slows, often because of carnitine or riboflavin deficiency.

8. Mineral cofactor markers. Methylcitric acid elevates when propionate clearance is impaired, sometimes pointing to a biotin insufficiency.

Normal Ranges: How to Read the Reference Intervals

Each metabolite has its own reference interval, adjusted for urinary creatinine concentration to correct for hydration. There is no single "organic acids score."

Age and Sex Adjustments

Pediatric ranges differ from adult ranges substantially. Methylmalonic acid reference upper limits in children under 2 years old extend to roughly 5.0 mmol/mol creatinine versus 3.56 in adults. Quinolinic acid tends to run higher in post-menopausal women, reflecting shifts in tryptophan catabolism driven by declining estrogen (PMID 22771461).

The Genova Report Layout

Results print as a color-coded spectrum from low to high, with each marker positioned against a shaded reference band. Values in the white center zone are within range. Values in yellow (borderline) or red (outside range) prompt clinical review. Most practitioners treat a single borderline marker cautiously and prioritize action only when two or more markers in the same functional cluster are elevated simultaneously.

When a "Normal" Result Still Matters

Pattern recognition across clusters matters more than individual outliers. A person with all markers individually within range but with Krebs-cycle intermediates clustered at the high end of normal, combined with MMA at the high end of normal, may still benefit from a therapeutic B12 and magnesium trial. This is the core reason organic acids panels are interpreted by clinicians, not automated algorithms alone.

What a High Result Means and How It Changes Treatment

Elevated markers are the most common finding prompting a protocol change. The direction and magnitude of elevation guide whether the intervention is dietary, supplemental, or pharmaceutical.

High Methylmalonic Acid (MMA)

High urine MMA above 3.56 mmol/mol creatinine is the functional gold standard for B12 insufficiency. The response protocol follows a defined sequence. First, confirm serum B12 and homocysteine. If serum B12 is below 400 pg/mL alongside elevated MMA, most integrative guidelines recommend methylcobalamin 1,000-2,000 mcg daily sublingually or hydroxocobalamin 1,000 mcg intramuscular injection weekly for 4-6 weeks, then monthly maintenance. Retest urine MMA at 12 weeks. If serum B12 is above 400 pg/mL but MMA is still high, consider a methylation pathway issue and add 5-MTHF (methylfolate) 400-800 mcg daily alongside the B12.

Clinicians also rule out metformin use, which independently raises MMA by reducing B12 absorption at the terminal ileum. The American Diabetes Association's Standards of Care note that "long-term use of metformin is associated with biochemical vitamin B12 deficiency" and recommend B12 monitoring every 1-2 years in patients on metformin who also have risk factors for deficiency (ADA Standards of Medical Care in Diabetes 2024, Section 5).

High Arabinose

Arabinose above the 95th percentile consistently suggests intestinal yeast overgrowth, most commonly Candida species. The clinical response is a structured antifungal and dietary protocol. A low-sugar, low-refined-carbohydrate diet reduces the substrate fueling yeast fermentation. Saccharomyces boulardii (CNCM I-745) 250-500 mg twice daily has shown efficacy in multiple randomized trials for gut flora rebalancing; a Cochrane-reviewed meta-analysis confirmed its tolerability across 3,114 patients in 31 trials (Cochrane Library 2020). For persistent or severe elevations, prescription fluconazole 100-150 mg for 7-14 days may be warranted, with retesting at 6-8 weeks.

High HPHPA

HPHPA elevation signals Clostridium-related dysbiosis. Clostridia metabolites inhibit dopamine-beta-hydroxylase, the enzyme converting dopamine to norepinephrine. This can produce a clinical picture of dopamine excess and relative norepinephrine deficiency: fatigue, mood instability, poor stress response. The treatment protocol typically includes high-dose probiotic therapy (Lactobacillus rhamnosus GG or Lactobacillus acidophilus, minimum 10 billion CFU twice daily) and dietary fiber modification to 25-35 g per day. Vancomycin 125 mg four times daily for 10 days is occasionally prescribed for severe cases, though the risk of further dysbiosis limits routine use.

High 8-OHdG

Elevated 8-OHdG is a broad signal of oxidative DNA damage. Treatment targets include N-acetylcysteine (NAC) 600-1,200 mg daily to replenish glutathione precursors, vitamin C 500-1,000 mg daily, and alpha-lipoic acid 300-600 mg daily. Lifestyle modifications carry at least equal weight. A 12-week exercise intervention in sedentary adults reduced 8-OHdG by a mean of 24% in a 2019 controlled trial (N=88) (PMID 31340643). Smoking cessation is non-negotiable when this marker is high.

High Succinic Acid

Succinic acid (succinate) accumulation suggests a block at succinate dehydrogenase, the enzyme requiring FAD (riboflavin). The first intervention is riboflavin (B2) 100-200 mg daily. Coenzyme Q10 (CoQ10) 200-400 mg daily supports downstream electron transport. If riboflavin supplementation and retesting at 12 weeks show no reduction, genetic testing for succinate dehydrogenase subunit mutations (SDHA, SDHB, SDHC, SDHD) may be indicated, since these mutations have clinical implications beyond mitochondrial function.

What a Low Result Means and How It Changes Treatment

Low markers receive less attention in most functional medicine discussions, but several are clinically significant.

Low Citric Acid

Citric acid below the 5th percentile indicates under-activity of the Krebs cycle at the citrate synthase step. This can reflect magnesium insufficiency, since citrate synthase requires magnesium as a cofactor. Magnesium glycinate or magnesium malate 200-400 mg elemental magnesium daily is a standard first intervention. Retesting at 8-12 weeks typically shows normalization if magnesium was the rate-limiting factor.

Low HVA/VMA Ratio

A low homovanillic acid to vanillylmandelic acid ratio suggests dopamine is being manufactured but not being efficiently converted to norepinephrine. The cofactor for dopamine-beta-hydroxylase is vitamin C and copper. Low copper is occasionally the culprit; a serum ceruloplasmin and copper panel confirms this. Copper bisglycinate 2-4 mg daily corrects most dietary copper shortfalls within 8 weeks.

Low Pyroglutamic Acid

Pyroglutamic acid at the very low end, paradoxically combined with low cysteine metabolites, can indicate glutathione overconsumption rather than production failure. This pattern sometimes appears after aggressive acetaminophen use or heavy toxic metal exposure. It guides the clinician toward a NAC loading protocol and, if metals exposure is suspected, a urine metals provocation test.

How a Full Protocol Gets Built From the Panel

No single marker drives a complete treatment change in isolation. A functional medicine clinician builds what is effectively a hierarchy of metabolic priorities.

The HealthRX Organic Acids Treatment Prioritization Framework ranks intervention targets across four tiers:

Tier 1 (Immediate action, highest clinical weight): Methylmalonic acid above 5.0 mmol/mol creatinine; 8-OHdG in the top 10% of the reference range; arabinose above the 95th percentile with concurrent GI symptoms.

Tier 2 (Address within 2-4 weeks, moderate clinical weight): Elevated HPHPA; low citric acid with fatigue as chief complaint; elevated quinolinic acid with cognitive or mood complaints.

Tier 3 (Address after Tier 1 and 2 stabilized, supportive interventions): Mild Krebs-cycle intermediate elevation without clear cofactor deficiency; borderline oxidative stress markers without identifiable lifestyle driver.

Tier 4 (Monitor only, retest in 3-6 months): Single borderline marker without corroborating clinical signs or companion abnormal markers in the same cluster.

This tiered approach prevents patients from leaving an appointment with a 12-supplement protocol they will not sustain. Starting with two or three targeted interventions and retesting produces better adherence and clearer attribution of benefit.

The Relationship Between Organic Acids and Hormone Therapy

Organic acid findings directly modify hormone therapy decisions at HealthRX in several specific ways.

Estrogen Metabolism and Oxidative Stress Markers

Elevated 8-OHdG in a peri-menopausal patient considering estrogen therapy (ET) signals that oxidative stress management should precede or accompany ET initiation. A 2020 analysis published in the Journal of Clinical Endocrinology and Metabolism found that baseline oxidative stress burden modifies the cardiovascular risk profile of estrogen therapy in women aged 50-59 (PMID 32142146). Clinicians at HealthRX routinely request repeat 8-OHdG at 12 weeks post-antioxidant protocol before finalizing ET dosing.

Testosterone and Mitochondrial Markers

Men beginning testosterone replacement therapy (TRT) with elevated adipic acid or ethylmalonic acid on organic acids testing may have a carnitine or riboflavin bottleneck limiting their beta-oxidation capacity. Since TRT increases erythropoiesis and metabolic demand, correcting a pre-existing mitochondrial substrate deficiency first may improve the patient's subjective response to TRT and reduce fatigue complaints in the first 60 days on therapy.

GLP-1 Receptor Agonists and Gut Dysbiosis Markers

Patients starting semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) who show high arabinose or HPHPA on baseline organic acids may experience disproportionate GI side effects. The existing dysbiosis creates an inflamed gut lining less tolerant of the gastric-emptying delay GLP-1 agents produce. Addressing the dysbiosis first, or starting the GLP-1 agent at a very slow titration (2.5 mg tirzepatide weekly for 8-12 weeks before advancing), is the approach this finding supports.

How to Collect the Sample Correctly

Sample quality determines result validity. Errors are common and preventable.

First-morning urine is required. The patient discards the first void on waking, then collects the second void of the morning in the provided container. This second void best reflects overnight metabolic byproduct accumulation without the dilution effect of daytime fluid intake.

Dietary preparation matters for a subset of markers. Patients should avoid bananas, avocados, pineapple, kiwi, and walnuts for 48 hours before collection; these foods directly raise VMA, HVA, and several other markers. Some clinicians also restrict vitamin C supplements above 500 mg for 48 hours before collection to avoid artificially suppressing oxidative stress markers.

The sample requires freezing within 2 hours of collection and shipping overnight on dry ice. A sample that sits unfrozen for 6 hours or more degrades several organic acids, particularly the shorter-chain metabolites, producing falsely low results.

Retesting: When and Why the Second Panel Matters

A single organic acids test is a snapshot. Its clinical value compounds when the second test, run 3-6 months after an intervention, confirms whether the metabolic target shifted.

Retesting MMA after 12 weeks of methylcobalamin therapy is standard practice. If MMA normalizes, the diagnosis of functional B12 insufficiency is confirmed and the intervention was appropriate. If MMA remains elevated despite documented adherence to methylcobalamin, the clinician should re-evaluate absorption (Helicobacter pylori testing, intrinsic factor antibodies) or consider a genetic methylation variant (MTHFR C677T, MTRR A66G) requiring higher-dose cofactor support.

Retesting arabinose 6-8 weeks after a structured antifungal and probiotic protocol confirms eradication or documents persistence. Persistent high arabinose after two rounds of treatment warrants consideration of an upper-GI source of overgrowth (small intestinal fungal overgrowth, SIFO) rather than solely colonic dysbiosis.

The National Institutes of Health Office of Dietary Supplements notes that functional markers like MMA and FIGLU offer sensitivity advantages over serum vitamin levels alone for detecting tissue-level deficiency (NIH ODS B12 Fact Sheet).

Limitations of the Test

Urine organic acids testing is not a diagnostic test for specific diseases in the conventional sense. It is a functional tool. Several limitations apply.

The reference intervals come from relatively small normative populations. Genova's published ranges are derived from self-reported healthy volunteers, and ethnicity-specific data are limited. A marker at the 96th percentile may be the patient's personal normal. Context from the clinical history must always accompany the numbers.

The panel does not replace conventional diagnostics for mitochondrial disease. Definitive mitochondrial disease diagnosis requires muscle biopsy, mitochondrial DNA sequencing, and respiratory chain enzyme assays. Organic acids provide a screening signal, not a definitive diagnosis (PMID 29409867).

Medications alter several markers. Valproic acid elevates adipic acid and multiple dicarboxylic acids independently of true beta-oxidation dysfunction. Antibiotics given in the week before collection can suppress gut microbial markers like arabinose and HPHPA, producing false negatives. Metformin, as noted above, affects MMA interpretation. Every result review should include a current medication list.

The panel costs USD 300-400 out of pocket at most functional medicine practices. Insurance rarely covers it. For patients with limited resources, prioritizing serum MMA, homocysteine, and a stool microbiome panel as lower-cost proxies for the most actionable organic acid findings is a reasonable alternative.